fanfilcon A
Devicecontact lens
NCT Number: NCT02921412
This is a prospective, multi-center, subject-masked, bilateral, daily wear, two-month dispensing study
Looking for future studies?
Notify Me18 year–40 year
All sexes
Interventional
Not applicable
Hospital Contact Lens Service, Miami, Florida, United States
The aim of this study is to determine if adapted contact lens wearers enfilcon A toric lenses can be confidently refit into fanfilcon A toric lenses and can be successful after one month of daily wear.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A person is eligible for inclusion in the study if he/she:
Exclusion criteria
A person will be excluded from the study if he/she:
contact lens
Time frame: baseline, 2 weeks, 1 month
High contrast distance visual acuity is measured by LogMAR.
Time frame: baseline, 2 weeks, 1 month
Lens centration is assessed (optimum, decentration acceptable, decentration unacceptable).
Time frame: baseline, 2 weeks, 1 month
Corneal coverage will be assessed (yes/no)
Time frame: baseline, 2 weeks, 1 month
Post-blink lens movement assessed using the following evaluations (0-4): 0=Insufficient, unacceptable, 1=Minimal, acceptable, 2=Optimal, 3=Moderate, acceptable, 4=Excessive, unacceptable)
Time frame: baseline, 2 weeks, 1 month
Investigator fit acceptability for each lens pair. Scale 0-4: (0=should not be worn, 1=borderline but unacceptable, 2=minimally acceptable, early review, 3=not perfect but OK to dispense, 4=perfect)
CooperVision, Inc.
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06775509
Astigmatism, Eye Diseases
Tarragona, Spain
View Trial DetailsNCT06784063
Astigmatism, Cataract
Bloomfield Hills, Michigan, United States
View Trial DetailsNCT06749496
Astigmatism, Eye Diseases
Jacksonville, Florida, United States
View Trial DetailsNCT06967129
Astigmatism, Eye Diseases
Mission Viejo, California, United States
View Trial Details